Stockscreener 앱 받기
90.00
1.64%
-1.50
전일 마감가:
$91.50
열려 있는:
$91.79
하루 거래량:
5.18M
Relative Volume:
0.94
시가총액:
$132.48B
수익:
$15.91B
순이익/손실:
$1.79B
주가수익비율:
109.76
EPS:
0.82
순현금흐름:
$1.89B
1주 성능:
+3.46%
1개월 성능:
+2.26%
6개월 성능:
+19.41%
1년 성능:
+62.37%
1일 변동 폭
$89.02
$91.93
1주일 범위
$88.50
$91.93
52주 변동 폭
$53.93
$91.93
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| BSX | 90.00 | 132.48B | 15.91B | 1.79B | 1.89B | 0.82 |
| ABT | 117.76 | 202.38B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 384.85 | 148.73B | 21.97B | 3.59B | 3.21B | 6.74 |
| MDT | 86.21 | 109.22B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 70.48 | 41.57B | 6.60B | 4.16B | 490.10M | 2.34 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Insider Sell: Edward Ludwig Sells Shares of Boston Scientific Co - GuruFocus.com
Boston Scientific (BSX) Announces 2025 Compensation Plans - GuruFocus.com
Boston Scientific director sells $446,901 in stock - Investing.com
Boston Scientific sets 2025 bonus, performance plans - Investing.com
Boston Scientific Launches 2025 Incentive Programs - TipRanks
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific (FRA:BSX) Purchase Of Investment : €0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) 5-Year EBITDA Growth Rate : 7.40% (As of Sep. 2024) - GuruFocus.com
Boston Scientific (FRA:BSX) Total Inventories : €2,480 Mil (As of Sep. 2024) - GuruFocus.com
Boston Scientific Corporation (BSX)’s Breakthroughs: A Hidden Gem in Billionaire Ken Griffin’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Stake Boosted by PNC Financial Services Group Inc. - MarketBeat
Boston Scientific Stock Set to Gain From Completion of Axonics Deal - Yahoo Finance
Boston Scientific Corp (BSX) Shares Up 3.98% on Nov 19 - GuruFocus.com
Boston Sci study shows Watchman Flx better OPTION than DOAC - BioWorld Online
Boston Scientific Completes $3.7B Acquisition of Axonics - Orange County Business Journal
Boston Scientific reiterates Buy stock rating on Option study - Investing.com
Boston Scientific stock soars to all-time high of $89.33 - Investing.com
Boston Scientific stock soars to all-time high of $89.33 By Investing.com - Investing.com Canada
Here's Why We Think Boston Scientific (NYSE:BSX) Might Deserve Your Attention Today - Yahoo Finance
Boston Scientific’s Watchman could be new option for patients post ablation: study - Yahoo Finance
Boston Scientific acquires Axonics - Medical Buyer
Boston Scientific reports outcomes from trial of LAAC device - Yahoo Finance
Boston Scientific to Acquire Cortex - Today's Medical Developments
Boston Scientific's WATCHMAN FLX Shows Superior Bleeding Risk Reduction in 3-Year Study | BSX Stock News - StockTitan
Boston Scientific (BSX) Completes Acquisition of Axonics - GuruFocus.com
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific put volume heavy and directionally bearish - TipRanks
Boston Scientific Closes $3.7B Deal for Axonics - MPO-mag
Boston Scientific Closes Acquisition of Axonics, Inc. - Quantisnow
Boston Scientific Completes $3.7B Axonics Acquisition, Expands Urology Portfolio | BSX Stock News - StockTitan
Boston Scientific closes $3.7B Axonics deal after lengthy review - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
SoniVie Names Axonics' Raymond Cohen as Chairman Following $3.7B Boston Scientific Deal | BSX Stock News - StockTitan
Boston Scientific Co. (NYSE:BSX) Shares Bought by Huntington National Bank - MarketBeat
Investing in Boston Scientific (NYSE:BSX) three years ago would have delivered you a 113% gain - Yahoo Finance
Urology Devices Market to Surpass Market Valuation of USD 61.62 Billion by 2031 | SkyQuest Technology - Benzinga
Boston Scientific EVP John Sorenson sells $2.68m in stock - Investing.com
Boston Sci charges ahead with AVANT GUARD PFA trial - BioWorld Online
Boston Scientific To Present At 2024 UBS Global Healthcare Conference; Webcast At 10:15 AM ET - Nasdaq
Boston Scientific resumes PFA trial in new patient group after pausing enrollment - Yahoo Finance
Boston Scientific resumes enrolment in pulsed field ablation trial - Yahoo Finance
BSXBoston Scientific Corp. Latest Stock News & Market Updates - StockTitan
Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now - Insider Monkey
Boston Scientific Corporation (BSX): A Hot Growth Stock to Buy According to Hedge Funds - Insider Monkey
Van ECK Associates Corp Has $5.06 Million Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
8 Hot Growth Stocks To Buy According to Hedge Funds - Insider Monkey
Boston Scientific stock soars to all-time high of $88.81 - Investing.com
We Think Boston Scientific's (NYSE:BSX) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Petri Dish: Boston Scientific resumes atrial fibrillation trial; Seaport hires CFO - The Business Journals
Boston Scientific CEO sells shares worth $13.8 million By Investing.com - Investing.com Canada
Boston Scientific CEO sells shares worth $13.8 million - Investing.com
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.36%
1.73%
자본화:
|
볼륨(24시간):